LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹5.32 Cr | ₹2.84 Cr | ₹6.54 Cr | ₹8.41 Cr | ₹11 Cr |
What is the latest Total Non-Current Liabilities ratio of LASA SUPERGENERICS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹5.32 Cr |
Mar2023 | ₹2.84 Cr |
Mar2022 | ₹6.54 Cr |
Mar2021 | ₹8.41 Cr |
Mar2020 | ₹11 Cr |
How is Total Non-Current Liabilities of LASA SUPERGENERICS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹5.32 Cr | 87.33 | |
Mar2023 | ₹2.84 Cr | -56.54 | |
Mar2022 | ₹6.54 Cr | -22.25 | |
Mar2021 | ₹8.41 Cr | -26.44 | |
Mar2020 | ₹11 Cr | - |
Compare Total Non-Current Liabilities of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹42.4 Cr | -6% | -19.3% | -74.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,100.0 Cr | -5.6% | -9.9% | -12.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,698.0 Cr | -2.5% | -8.4% | 21.7% | Stock Analytics | |
CIPLA | ₹128,239.0 Cr | -0.8% | 1.8% | -1.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,216.0 Cr | -2.4% | -4% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,855.0 Cr | -0.3% | -0.9% | -9.7% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | -6% |
-19.3% |
-74.3% |
SENSEX | -1.2% |
-1.2% |
-1.7% |
You may also like the below Video Courses